Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,011.00
+53.00 (5.53%)
Sep 1, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 67.49 billion as of September 1, 2026. Its market cap has decreased by -64.05% in one year.
Market Cap
67.49B
Enterprise Value
122.91B
Revenue
43.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,011.00
ChartMarket Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 67.49B, a decrease of -71.54%. That is a compound annual growth rate of -9.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 67.49B | -31.79% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC Genome | 141.20B |
| Genexine | 120.29B |
| MedPacto | 93.91B |
| Vaxcell-Bio Therapeutics | 93.15B |
| iNtRON Biotechnology | 87.89B |
| Prestige BioPharma | 77.28B |
| ENCell | 66.51B |
| ORIENT BIO | 52.11B |